The FDA has approved a device that aims to treat depression by sending electric current into a part of the brain known to ...

Flow Neuroscience announced that the FDA approved its Flow at-home brain stimulation device for treating major depressive ...

The FDA recently cleared this device for sale in the U.S. Research shows it can improve moderate to severe depression ...

By Dennis Thompson HealthDay ReporterMONDAY, Dec. 8, 2025 (HealthDay News) — Laughing gas might live up to its name for ...

A new analysis shows that anti-inflammatory medications may help reduce symptoms for a subset of people with depression who ...

The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience.  | The FDA issued a green light that covers the ...

Learn the nine key warning signs that may indicate it’s time for a depression screening. Understand when low mood, fatigue, or changes in sleep could signal something more serious.

Investing.com -- Aytu BioPharma (NASDAQ:AYTU) stock gained 2.6% on Monday after the company announced the commercial availability of its newly approved depression treatment EXXUA in the United States.

Depression has been tied to a two-fold increased risk offor epilepsy and a suboptimal response to initial therapy, ...

A Pune woman shares how talk therapy helped her overcome depression after medicines failed, highlighting benefits, process, ...